This page shows the latest Azithromycin news and features for those working in and with pharma, biotech and healthcare.
In January, the PRINCIPLE study also found that the commonly-used antibiotics azithromycin and doxycycline are not generally effective in certain patients with early COVID-19.
The UK-based PRINCIPLE study has found that the commonly-used antibiotics azithromycin and doxycycline are not generally effective in certain patients with early COVID-19. ... up. There was also no evidence that azithromycin reduced COVID-19-associated
This data supports earlier preliminary results from a small study of hydroxychloroquine in combination with the antibiotic azithromycin, and as a monotherapy. ... Although the drug was effective on its own, when added to the antibiotic azithromycin,
Although the drug was effective on its own, when added to the antibiotic azithromycin, hydroxycholoroquine was found to produce a superior response, by a significant margin. ... Analysts from Dawson James Securities concluded that "hydroxychloroquine
to the recommended first-choice treatment – a combination of azithromycin and ceftriaxone. ... EAGLE-1 will compare gepotidacin – a triazaacenaphthylene bacterial topoisomerase inhibitor developed in collaboration with US federal agencies – to the
gonorrhoeae that proved to be incurable using first-choice antibiotics (azithromycin and ceftriaxone).
More from news
Approximately 1 fully matching, plus 17 partially matching documents found.
An earlier study of 24 COVID-19 patients, also conducted by Raoult, found that within six days of taking hydroxychloroquine and the antibiotic azithromycin, the symptoms of the virus disappeared in
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...